ReviewBiomedicines2022

Targeting Tyrosine Kinases in Ovarian Cancer: Small Molecule Inhibitor and Monoclonal Antibody, Where Are We Now?

Aimee Rendell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.